Intracerebroventricular microinjection of the 5-HT 1F receptor agonist LY 344864 inhibits methamphetamine conditioned place preference reinstatement in rats

Relapse following a prolonged period of drug cessation is a key barrier in the treatment of methamphetamine (METH) addiction, for which pharmacological treatment exhibits little efficacy. Previous studies have suggested that this process involves alterations in levels of serotonin (5-HT) in the brai...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pharmacology, biochemistry and behavior Jg. 173; S. 27
Hauptverfasser:	Shahidi, Siamak, Sadeghian, Reihaneh, Komaki, Alireza, Asl, Sara Soleimani
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.10.2018
Schlagworte:	Amphetamine-Related Disorders - physiopathology Amphetamine-Related Disorders - psychology Animals Carbazoles - administration & dosage Carbazoles - pharmacology Central Nervous System Stimulants - pharmacology Conditioning, Classical - drug effects Dose-Response Relationship, Drug Fluorobenzenes - administration & dosage Fluorobenzenes - pharmacology Injections, Intraventricular Male Methamphetamine - pharmacology Rats Rats, Wistar Receptor, Serotonin, 5-HT1F Receptors, Serotonin - drug effects Recurrence Serotonin Receptor Agonists - pharmacology Relapse Conditioned place preference Serotonin receptor Methamphetamine
ISSN:	1873-5177
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!